Accepted for/Published in: JMIR Research Protocols
Date Submitted: Apr 5, 2024
Open Peer Review Period: Apr 8, 2024 - Jun 3, 2024
Date Accepted: Jul 17, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effects of Defatted Rice Bran Fortified Bread on Gut Microbiota Composition of Healthy Adults with Low Dietary Fibre Intake: Protocol for a Crossover Randomised Controlled Trial
ABSTRACT
Background:
Inadequate dietary fiber (DF) intake is associated with several human diseases. Bread is commonly consumed, and can increase its DF content by incorporating defatted rice bran (DRB).
Objective:
This first human study on DRB fortified bread, primarily aims to assess the effect of DRB bread on the relative abundance of a composite of key microbial genera and species in stool samples. Secondary outcomes include clinical (cardiovascular risk profile), patient-reported (daily bread consumption and bowel movement, digestive comfort, general well-being, total DF intake), biological (stool microbiota gene abundances, stool and plasma metabolites). Exploratory outcomes include physiome (whole gut and regional transit time, and gas fermentation profiles) outcomes in healthy adults with low DF intake.
Methods:
The BREAD (Bread Related Effects on Microbial Distribution) study is a two-armed, placebo-controlled, double-blind, randomized, crossover study. The study duration is fourteen weeks: two weeks lead-in, four weeks intervention per phase, two weeks washout, and two weeks follow-up. Sixty healthy adults with low DF intake (<18g/day (females), <22g/day (males)) were recruited in Christchurch, New Zealand between June and December 2022. Randomized participants consumed three (for females)/ four (for males) slices of fortified bread per day, then placebo white bread and vice versa. The DRB fortified bread provided 8 g (for females) and 10.6 g (for males) of total DF, while the placebo (a matched commercial white toast bread) provided 2.7 g for females and 3.6 g for males of total DF. Before and after each intervention phase, participants provided stool and blood samples to assess biological responses; completed a three-day food diary to assess usual intakes; online questionnaires to assess gut symptoms, general and mental well-being, daily bread intake and bowel movement via an app; underwent anthropometry and blood pressure measurements; drank blue food dye to assess whole gut transit time. In addition, 15 participants from the cohort ingested Atmo gas-sensing capsules to assess gut regional’s fermentation gas profile.
Results:
At the time of writing, data was still being analysed. Results will be published as separate manuscripts.
Conclusions:
This study will offer insights into the prospect of consuming DRB fortified bread to effectively modulate health-promoting gut microbes and their metabolism, and DF intake in healthy adults with low DF intake. Clinical Trial: ACTRN12622000884707
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.